🔎 Trials Near Me

Akèy › Glomerulonefrit IGA › Ohio

Etid klinik pou Glomerulonefrit IGA nan Ohio

4 etid pou Glomerulonefrit IGA ap chèche patisipan nan sit nan Ohio.

Vil nan Ohio

Tèks ofisyèl etid la (Anglè)

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

  • Cincinnati Childrens Hospital MC, Cincinnati
Ap rekriteFaz 3
Laj 2 a 18 · Tout sèks · Mizajou Sep 21, 2026 · NCT07498335

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

  • ADARx Clinical Site, Columbus
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06989359

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

  • University Hospitals Cleveland Medical Center, Cleveland
  • OSU Wexner Medical Center, Columbus
Ap rekriteFaz 2
Laj 18 a 99 · Tout sèks · Mizajou Jul 29, 2026 · NCT06797518

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

  • Nationwide Children's Hospital, Columbus
Ap rekriteFaz 2
Laj 1 a 17 · Tout sèks · Mizajou May 12, 2026 · NCT05003986

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.